Media

Media

Zuvius Launches Zinotecan in 100mg, and 40 mg

Admin / May 16, 2015 / Graphic, Illustration, Logo

Zuvius Launches Zinotecan in 100mg, and 40 mg, used in the treatment of Cancer. 

ZINOTECAN (IRINOTECAN INJECTION IP)

 COMPOISTION

Each ml contains:

Irinotecan Hydrochloride Trihydrate IP…. 20mg

Water for injection IP ……………………………. q.s.

 Indications :

  • Irinotecan Hydrochloride is indicated is a component of first-line therapy in combination with 5-fluorouracil and Leucovorin for patients with metastatic carcinoma of the colon or rectum.
  • Irinotecan Hydrochloride is also indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial fluorouracil-based therapy.

Packing :

20 mg/mL Single-Use Vial

40 mg/2mL Single-Use Vial

100 mg/5mL Single-Use Vial

TOP
Login
Forgot Password ?

Not a member as yet? Register Now

In case you are using a public/shared computer we recommend that
you logout to prevent any un-authorized access to your account

forgot password

Reset Your Password

Enter email address to receive an email with the link to reset your password.

New User

hello , who are you?

I am a? *

Create Login Details

your contact details

I have read and understood and agree to Terms and Conditions the governing the use of zuviuslifescience.in.